Scalable biomimetic SARS-CoV2 nanovaccines with robust protective immune responses.
Signal Transduct Target Ther
; 7(1): 96, 2022 03 25.
Article
in English
| MEDLINE | ID: covidwho-1758180
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19
Limits:
Humans
Language:
English
Journal:
Signal Transduct Target Ther
Year:
2022
Document Type:
Article
Affiliation country:
S41392-022-00942-Y
Similar
MEDLINE
...
LILACS
LIS